Cholesterol inhibits the nuclear entry of estrogen receptor activation factor (E-RAF) and its dimerization with the nonactivated estrogen receptor (naER) in goat uterus

Journal of Cellular Biochemistry

Volumn 77, Issue 3, 2000, Pages 382-395

  Thampan, Raghava Varman ^a   Zafar, Atya ^b,d   Imam, N S ^b   Sreeja, S ^a   Suma, K ^c   Vairamani, M ^c  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b UNIVERSITY OF HYDERABAD   (India)

^c INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^d NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

Cholesterol; Estrogen receptor activation factor; Goat uterus; Nonactivated estrogen receptor; Nuclear migration

Indexed keywords

CHOLESTEROL; DNA BINDING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ACTIVATION FACTOR; MEMBRANE PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; DIMERIZATION; FEMALE; GOAT; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; PROTEIN TERTIARY STRUCTURE; UTERUS;

ANIMALS; CELL NUCLEUS; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTENONES; CHOLESTEROL; CHROMATOGRAPHY, THIN LAYER; CIRCULAR DICHROISM; DIMERIZATION; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GOATS; MASS SPECTROMETRY; PROTEIN BINDING; PROTEINS; RECEPTORS, ESTROGEN; UTERUS;

ANIMALIA; CAPRA HIRCUS;

EID: 0342368988     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(20000601)77:3<382::AID-JCB4>3.0.CO;2-L     Document Type: Article

References (27)

1. Alberts BM, Herrick G. 1971. DNA cellulose chromatography. Methods Enzymol 21:198-217.
2. Anuradha P, Khan SM, Karthikeyan N, Thampan RV. 1994. The non-activated estrogen receptor (naER) of the goat uterus is a tyrosine kinase. Arch Biochem Biophys 309:195-204.
3. Bailly A, Le Fevre B, Savouret JF, Milgrom E. 1980. Activation and changes in sedimentation properties of steroid receptors. J Biol Chem 255:2729-2734.
4. Clark JH, Peck EJ Jr. 1979. Female sex steroids: receptors and function. Berlin: Springer-Verlag.
5. Cypriani B, Tabacik C, Descomps B. 1988. Effect of estradiol and antiestrogen on cholesterol biosynthesis in hormone dependent breast cancer cell lines. Biochim Biophys Acta 972:167-178.
6. Grody WW, Schrader WT, O'Malley BW. 1982. Activation, transformation and subunit structure of steroid hormone receptors. Endocr Rev 3:141-143.
7. Higgins SJ, Rousseau GG, Baxter JD, Tomkins GM. 1973. Early events in glucocorticoid action: activation of the steroid receptor and its specific nuclear binding studied in a cell-free system. J Biol Chem 248:5866-5871.
8. Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, Wang X. 1993. SREBP-2. A second basic helixloop helix leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 90:11603-11607.
9. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS. 1995. Hairpin orientation of sterol regulatory element binding protein 2 in cell membranes as determined by protease protection. J Biol Chem 270:29422-29427.
10. Karthikeyan N, Thampan RV. 1996. Plasma membrane is the primary site of localization of the non-activated estrogen receptor in the goat uterus: hormone binding causes receptor internalization. Arch Biochem Biophys 321:442-452.
11. Marmur J. 1961. A procedure for the isolation of DNA from microorganisms. J Mol Biol 3:208-219.
12. Rosenberg L, Armstrong B, Jick H. 1976. Myocardial infarction and estrogen therapy in post menopausal women. N Engl J Med 294:1256-1259.
13. Sato B, Husley RA, Samules LT. 1978. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4S to 5S. Endocrinology 102:545-550.
14. Sato B, Nona K, Nishizawa Y, Nakao K, Matsumoto K, Yamamoto Y. 1980. Mechanism of action of steroid receptors: involvement of a low molecular weight inhibitor in activation of androgen, glucocorticoid and estrogen receptor systems. Endocrinology 106:1142-1148.
15. Sherman B, Wallace R, Bean J. 1983. Estrogen use and breast cancer: interaction with body mass. Cancer 51: 1527-1531.
16. Tachibana Y. 1986. A convenient synthesis of cholesta-1,5,7-trien-3βol. Bull Chem Soc Jpn 59:3702.
17. Thampan RV. 1985. The nuclear binding of estradiol stimulates ribonucleoprotein transport in the rat uterus. J Biol Chem 260:5420-5426.
18. Thampan RV. 1987. A 62 kDa protein functions as estrogen receptor activation factor (E-RAF) in the goat uterus. Mol Cell Endocrinol 53:119-130.
19. Thampan RV. 1989. Molecular aspects of estrogen receptor activation factor function. Mol Cell Endocrinol 64: 19-34.
20. Thampan TNRV, Clark JH. 1981. An oestrogen receptor activator protein in rat uterine cytosol. Nature 290:152-154. conversion of estrogen receptor from 4S to 5S. Endocrinology 102:545-550.
21. Sato B, Nona K, Nishizawa Y, Nakao K, Matsumoto K, Yamamoto Y. 1980. Mechanism of action of steroid receptors: involvement of a low molecular weight inhibitor in activation of androgen, glucocorticoid and estrogen receptor systems. Endocrinology 106:1142-1148.
22. Sherman B, Wallace R, Bean J. 1983. Estrogen use and breast cancer: interaction with body mass. Cancer 51: 1527-1531.
23. Tachibana Y. 1986. A convenient synthesis of cholesta-1l,5,7-trien-3βol. Bull Chem Soc Jpn 59:3702.
24. Thampan RV. 1985. The nuclear binding of estradiol stimulates ribonucleoprotein transport in the rat uterus. J Biol Chem 260:5420-5426.
25. Thampan RV. 1987. A 62 kDa protein functions as estrogen receptor activation factor (E-RAF) in the goat uterus. Mol Cell Endocrinol 53:119-130.
26. Thampan RV. 1989. Molecular aspects of estrogen receptor activation factor function. Mol Cell Endocrinol 64:19-34.
27. Thampan TNRV, Clark JH. 1981. An oestrogen receptor activator protein in rat uterine cytosol. Nature 290:152-154.